Identification of the von Hippel-Lindau disease tumor suppressor gene.
暂无分享,去创建一个
J. Gnarra | F. Latif | F. Duh | K. Tory | M. Yao | M. Orcutt | T. Stackhouse | I. Kuzmin | W. Modi | L. Geil | F. Latif | T Stackhouse | J Gnarra | W Modi | F Latif | K Tory | M Yao | F M Duh | M L Orcutt | I Kuzmin | L Geil
[1] P. Choyke,et al. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. , 1990, Genomics.
[2] Raymond White. Inherited cancer genes , 1992 .
[3] A. Knudson,et al. Genetics of human cancer. , 1986, Annual review of genetics.
[4] Margaret Robertson,et al. Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.
[5] D. Paslier,et al. von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region. , 1993, Cancer research.
[6] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[7] M. Leppert,et al. Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients , 1990, Cell.
[8] M. Ferguson-Smith,et al. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. , 1990, Journal of medical genetics.
[9] J. Fickett. Recognition of protein coding regions in DNA sequences. , 1982, Nucleic acids research.
[10] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[11] Y. Nakamura,et al. Specific genetic change in tumors associated with von Hippel-Lindau disease. , 1989, Journal of the National Cancer Institute.
[12] S. Klauck,et al. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Lisanti,et al. Glycophospholipid membrane anchoring provides clues to the mechanism of protein sorting in polarized epithelial cells. , 1990, Trends in biochemical sciences.
[14] J. Haines,et al. Von HippelLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.
[15] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[16] R. Weinberg,et al. Tumor suppressor genes. , 1991, Science.
[17] M. Lush,et al. Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene. , 1993, Journal of medical genetics.
[18] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[19] B. Brownstein,et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.
[20] M. Ferguson. Lipid anchors on membrane proteins , 1991 .
[21] L. Schmidt,et al. A genetic linkage map of 96 loci on the short arm of human chromosome 3. , 1992, Genomics.
[22] N. Morton,et al. Von Hippel-Lindau disease: a genetic study. , 1991, Journal of medical genetics.
[23] G. Yancopoulos,et al. The receptor for ciliary neurotrophic factor. , 1991, Science.
[24] P. O'Connell,et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.
[25] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.